Other

Health News: Medicine - Nice extends drug options for ADHD

Children with Attention Deficit Hyperactivity Disorder (ADHD) will have greater access to a choice of medications suited to their individual needs, under new national guidelines.

Existing guidance recommends methylphenidate for children, sometimessold as Ritalin, which acts for short periods of time.

However, the National Institute for Clinical Excellence (Nice) hasrecommended two other medications as potential treatments for ADHD -dexamphetamine, also known as Dexedrine, and atomoxetine, also known asStrattera.

Andrea Bilbow, chief executive at ADHD charity Addiss, said bothmedications could help children who did not respond or responded poorlyto methylphenidate. She said the new medications were active for longerperiods and could fit around children's school and after-schoolactivities. "It can also help with the stigma as children don't have totake the medication at school."

- www.nice.org.uk.

Register Now to Continue Reading

Thank you for visiting Children & Young People Now and making use of our archive of more than 60,000 expert features, topics hubs, case studies and policy updates. Why not register today and enjoy the following great benefits:

What's Included

  • Free access to 4 subscriber-only articles per month

  • Email newsletter providing advice and guidance across the sector

Register

Already have an account? Sign in here


More like this

Hertfordshire Youth Workers

“Opportunities in districts teams and countywide”

Administration Apprentice

SE1 7JY, London (Greater)